Also found in: Medical, Wikipedia.
Category filter:
ACIPAdvisory Committee on Immunization Practices
ACIPAdvisory Council on Intellectual Property
ACIPAmerican Council on International Personnel
ACIPAsian Classics Input Project
ACIPAviation Career Incentive Pay
ACIPAsymptomatic Cardiac Ischemia Pilot
ACIPAirport Capital Improvement Program
ACIPAssociation des Cadres de l'Industrie Pharmaceutique
ACIPAnglican Council of Indigenous Peoples
ACIPAmerican College of International Physicians
ACIPAerodynamic Coefficient Identification Package (NASA)
ACIPArts and Culture Indicators in Community Building Project
ACIPArizona Counties Insurance Pool (Phoenix, AZ)
ACIPAugered Cast-In-Place Piles (construction foundations)
ACIPAssociation of Counter-Intelligence Professionals
ACIPATM Cable Interface Processor
ACIPAssembly Configuration and Integration Panel
ACIPAerodynamic Coefficient Instrumentation Package (Space Shuttle)
ACIPAutomated COSAL Improvement Program
ACIPAir Characteristics Improvement Panel
ACIPAir Conditioning Improvement Program
ACIPArmament Control Indicator Panel
ACIPAttack Center Indicator Panel
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
In 2007, ACIP recommended that the quadrivalent meningococcal conjugate vaccine (MCV4), sold under the brand names Menactra and Menveo, be given to 11-to 12-year-olds at the established preteen visit, and to 13- to 18-year-olds who had not been previously vaccinated.
Rosters of current and past members of the Advisory Committee on Immunization Practices (ACIP) are available at https://www.cdc.
Lauri Markowitz of the CDC, who presented the ACIP recommendations for the use of the bivalent vaccine.
At the February meeting of ACIP, the committee approved language that providers may provide any licensed, age-appropriate influenza vaccine, and LAIV4 is considered in this set of vaccine options.
For further guidance on the use of each vaccine included in the schedules, including contraindications and precautions, health care providers are referred to the respective ACIP vaccine recommendations at
Immuno-oncology company Agenus Inc (NASDAQ:AGEN) stated on Wednesday that the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) has voted in favor of three recommendations for the Shingrix (Zoster Vaccine Recombinant, Adjuvanted) vaccine with QS-21 Stimulon for the prevention of shingles (herpes zoster), a virus called varicella zoster, which is also known as the chicken pox virus.
"I think ACIP is likely to reconsider the issue of routine meningococcal conjugate vaccine for infants in October, with a possible vote on the matter in February,'" he predicted.
This evolving epidemiology of pertussis has prompted ACIP to recommend a routine single Tdap dose for adolescents between the ages of 11 and 18 years who have completed the recommended DTP/DTaP (diphtheria and tetanus toxoids and pertussis/diphtheria and tetanus toxoids and acellular pertussis) vaccination series and for adults ages 19 to 64 years.
A draft was prepared and presented at the ACIP meeting, at which the changes were unanimously approved by the 14-member advisory committee.
In June 2011, the ACIP changed its recommendation to one dose of the vaccine during pregnancy in women who had never received it before.
Cohn, who presented the draft of the recommendations at the ACIP meeting.